Increased urinary leukotriene E 4 concentration in patients with eosinophilic
暂无分享,去创建一个
N. Higashi | T. Tsuburai | M. Taniguchi | H. Mita | K. Akiyama | E. Ono | E. Miyazaki | T. Kumamoto | Y. Fukutomi | H. Tanimoto | K. Sekiya | O. Matsuno | C. Oshikata | N. Tsurikisawa | Y. Maeda | M. Otomo
[1] M. Taniguchi,et al. Quantification of leukotriene B4 glucuronide in human urine. , 2007, Prostaglandins & other lipid mediators.
[2] J. Hankinson,et al. Standardisation of the single-breath determination of carbon monoxide uptake in the lung , 2005, European Respiratory Journal.
[3] S. Anderson,et al. Evidence of mast cell activation and leukotriene release after mannitol inhalation , 2003, European Respiratory Journal.
[4] A. Menzies-Gow,et al. Eosinophils and interleukin-5: the debate continues. , 2003, American journal of respiratory and critical care medicine.
[5] Keiko Saito,et al. The Roles of Cysteinyl Leukotrienes in Eosinophilic Inflammation of Asthmatic Airways , 2003, International Archives of Allergy and Immunology.
[6] N. Higashi,et al. A comparative study of eicosanoid concentrations in sputum and urine in patients with aspirin‐intolerant asthma , 2002, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[7] P. O'Byrne,et al. Cysteinyl leukotrienes promote human airway smooth muscle migration. , 2002, American journal of respiratory and critical care medicine.
[8] I. Pavord,et al. Sputum cysteinyl leukotrienes increase 24 hours after allergen inhalation in atopic asthmatics. , 2000, American journal of respiratory and critical care medicine.
[9] H. Mita,et al. Efficient method for the quantitation of urinary leukotriene E4: extraction using an Empore C18 disk cartridge. , 1997, Journal of chromatography. B, Biomedical sciences and applications.
[10] A. Ammit,et al. Mast cell numbers are increased in the smooth muscle of human sensitized isolated bronchi. , 1997, American journal of respiratory and critical care medicine.
[11] M. Kumlin. Measurements of leukotrienes in the urine: strategies and applications , 1997, Allergy.
[12] S. Dahlén,et al. Increased urinary excretion of the prostaglandin D2 metabolite 9 alpha, 11 beta-prostaglandin F2 after aspirin challenge supports mast cell activation in aspirin-induced airway obstruction. , 1996, The Journal of allergy and clinical immunology.
[13] I. Strannegård,et al. Urinary eosinophil protein X in children with atopic asthma: a useful marker of antiinflammatory treatment. , 1996, The Journal of allergy and clinical immunology.
[14] H. Kita,et al. Cytokine production at the site of disease in chronic eosinophilic pneumonitis. , 1996, American journal of respiratory and critical care medicine.
[15] J. N. Allen,et al. Eosinophilic lung diseases. , 1994, American journal of respiratory and critical care medicine.
[16] R. Braun,et al. Activated T cells and cytokines in bronchoalveolar lavages from patients with various lung diseases associated with eosinophilia. , 1994, American journal of respiratory and critical care medicine.
[17] J. Bousquet,et al. Eosinophilic and neutrophilic inflammation in asthma, chronic bronchitis, and chronic obstructive pulmonary disease. , 1993, The Journal of allergy and clinical immunology.
[18] J. Bousquet,et al. Eosinophilic inflammation in asthma. , 1990, The New England journal of medicine.
[19] E. Pacht,et al. Acute eosinophilic pneumonia as a reversible cause of noninfectious respiratory failure. , 1989, The New England journal of medicine.
[20] F. Ogushi,et al. PGE2 and PGF2 alpha content in bronchoalveolar lavage fluid obtained from patients with eosinophilic pneumonia. , 1987, Chest.
[21] T. McLoud,et al. Normal chest roentgenograms in chronic diffuse infiltrative lung disease. , 1978, The New England journal of medicine.
[22] C. Carrington,et al. Chronic eosinophilic pneumonia. , 1969, The New England journal of medicine.